← All stories
Markets
Junshi Biosciences Announces 2026 Interim Financial Results and Provides Corporate Updates
SHANGHAI, Aug. 26, 2026 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercializ…
Covered by 1 outlet
All coverage · 1 article